Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Cogent Biosciences (COGT) Return on Sales (2017 - 2020)

Cogent Biosciences' Return on Sales history spans 4 years, with the latest figure at 0.1% for Q4 2020.

  • Quarterly Return on Sales fell 11.0% to 0.1% in Q4 2020 from the year-ago period, while the trailing twelve-month figure was 0.1% through Dec 2020, down 9.0% year-over-year, with the annual reading at 0.1% for FY2020, 9.0% down from the prior year.
  • Return on Sales came in at 0.1% for Q4 2020, up from 1.83% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2019 to a low of 1.83% in Q3 2020.
  • The 4-year median for Return on Sales is 0.03% (2017), against an average of 0.16%.
  • The largest YoY upside for Return on Sales was 3bps in 2020 against a maximum downside of -171bps in 2020.
  • Cogent Biosciences' Return on Sales stood at 0.03% in 2017, then grew by 29bps to 0.02% in 2018, then skyrocketed by 107bps to 0.0% in 2019, then tumbled by -7026bps to 0.1% in 2020.
  • Per Business Quant, the three most recent readings for COGT's Return on Sales are 0.1% (Q4 2020), 1.83% (Q3 2020), and 0.14% (Q2 2020).